Esak Lee

2.2k total citations
45 papers, 1.7k citations indexed

About

Esak Lee is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Esak Lee has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Esak Lee's work include Lymphatic System and Diseases (18 papers), Angiogenesis and VEGF in Cancer (14 papers) and Cancer Cells and Metastasis (12 papers). Esak Lee is often cited by papers focused on Lymphatic System and Diseases (18 papers), Angiogenesis and VEGF in Cancer (14 papers) and Cancer Cells and Metastasis (12 papers). Esak Lee collaborates with scholars based in United States, South Korea and Germany. Esak Lee's co-authors include Aleksander S. Popel, Niranjan B. Pandey, Christopher S. Chen, Girija Goyal, Oren Levy, Bryan Hassell, Donald E. Ingber, Alexandra Sontheimer-Phelps, Tae Joon Kwak and Elana J. Fertig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Esak Lee

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esak Lee United States 22 794 676 627 209 153 45 1.7k
Mara Gilardi United States 19 799 1.0× 838 1.2× 623 1.0× 196 0.9× 331 2.2× 33 1.9k
Susan Breslin Ireland 8 551 0.7× 823 1.2× 537 0.9× 232 1.1× 72 0.5× 10 1.5k
Marı́a Virumbrales-Muñoz United States 20 565 0.7× 906 1.3× 287 0.5× 116 0.6× 144 0.9× 38 1.3k
Witold W. Kilarski Switzerland 19 663 0.8× 189 0.3× 608 1.0× 145 0.7× 262 1.7× 44 1.5k
Manuele Giuseppe Muraro Switzerland 20 1.2k 1.5× 367 0.5× 469 0.7× 311 1.5× 513 3.4× 36 1.9k
Virginie Dangles-Marie France 8 787 1.0× 509 0.8× 459 0.7× 258 1.2× 113 0.7× 8 1.3k
Rajender Nandigama Germany 12 500 0.6× 280 0.4× 426 0.7× 193 0.9× 226 1.5× 21 1.3k
Dariusz Lachowski United Kingdom 16 569 0.7× 321 0.5× 551 0.9× 206 1.0× 191 1.2× 20 1.6k
Abisola Abisoye-Ogunniyan United States 5 586 0.7× 347 0.5× 589 0.9× 325 1.6× 243 1.6× 9 1.5k
Vasiliki Gkretsi Cyprus 24 498 0.6× 314 0.5× 722 1.2× 262 1.3× 219 1.4× 57 1.9k

Countries citing papers authored by Esak Lee

Since Specialization
Citations

This map shows the geographic impact of Esak Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esak Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esak Lee more than expected).

Fields of papers citing papers by Esak Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esak Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esak Lee. The network helps show where Esak Lee may publish in the future.

Co-authorship network of co-authors of Esak Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Esak Lee. A scholar is included among the top collaborators of Esak Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esak Lee. Esak Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Esak, et al.. (2025). Human ocular fluid outflow on-chip reveals trabecular meshwork-mediated Schlemm’s canal endothelial dysfunction in steroid-induced glaucoma. Nature Cardiovascular Research. 4(9). 1066–1076. 1 indexed citations
2.
3.
Peng, Yansong & Esak Lee. (2023). Microphysiological Systems for Cancer Immunotherapy Research and Development. Advanced Biology. 8(8). e2300077–e2300077. 7 indexed citations
4.
Vlaminck, Iwijn De, et al.. (2023). Abstract 4614: Investigating lymphatic vessel remodeling and anti-tumor immunity in pancreatic cancer using tumor-on-chip and mouse models. Cancer Research. 83(7_Supplement). 4614–4614. 1 indexed citations
5.
Peng, Yansong, et al.. (2023). A 3D Human Lymphatic Vessel-on-Chip Reveals the Roles of Interstitial Flow and VEGF-A/C for Lymphatic Sprouting and Discontinuous Junction Formation. Cellular and Molecular Bioengineering. 16(4). 325–339. 12 indexed citations
6.
Kim, Jiyoon, Jong Soo Lee, Jaeyoung Kwon, et al.. (2023). Identification of novel pathogenic roles of BLZF1/ATF6 in tumorigenesis of gastrointestinal stromal tumor showing Golgi-localized mutant KIT. Cell Death and Differentiation. 30(10). 2309–2321. 9 indexed citations
7.
Lee, Esak, et al.. (2022). Tissue engineering in age-related macular degeneration: a mini-review. Journal of Biological Engineering. 16(1). 11–11. 12 indexed citations
8.
Mair, Devin B., et al.. (2021). Engineering Three-Dimensional Vascularized Cardiac Tissues. Tissue Engineering Part B Reviews. 28(2). 336–350. 27 indexed citations
9.
Kwak, Tae Joon & Esak Lee. (2020). In vitro modeling of solid tumor interactions with perfused blood vessels. Scientific Reports. 10(1). 20142–20142. 66 indexed citations
10.
Choi, Dongwon, Eun-Kyung Park, Eunson Jung, et al.. (2017). Laminar flow downregulates Notch activity to promote lymphatic sprouting. Journal of Clinical Investigation. 127(4). 1225–1240. 108 indexed citations
11.
Hassell, Bryan, Girija Goyal, Esak Lee, et al.. (2017). Human Organ Chip Models Recapitulate Orthotopic Lung Cancer Growth, Therapeutic Responses, and Tumor Dormancy In Vitro. Cell Reports. 21(2). 508–516. 348 indexed citations
12.
Lee, Esak, et al.. (2016). The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts. Scientific Reports. 6(1). 39460–39460. 25 indexed citations
13.
Fertig, Elana J., Esak Lee, Niranjan B. Pandey, & Aleksander S. Popel. (2015). Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes. Scientific Reports. 5(1). 12133–12133. 43 indexed citations
14.
Lee, Esak, Niranjan B. Pandey, & Aleksander S. Popel. (2015). Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment. Expert Reviews in Molecular Medicine. 17. e3–e3. 63 indexed citations
15.
Lee, Esak, et al.. (2015). Biomimetic on-a-chip platforms for studying cancer metastasis. Current Opinion in Chemical Engineering. 11. 20–27. 40 indexed citations
16.
Lee, Esak, Niranjan B. Pandey, & Aleksander S. Popel. (2014). Lymphatic endothelial cells support tumor growth in breast cancer. Scientific Reports. 4(1). 5853–5853. 53 indexed citations
17.
Lee, Esak, Jacob E. Koskimaki, Niranjan B. Pandey, & Aleksander S. Popel. (2013). Inhibition of Lymphangiogenesis and Angiogenesis in Breast Tumor Xenografts and Lymph Nodes by a Peptide Derived from Transmembrane Protein 45A. Neoplasia. 15(2). 112–IN6. 44 indexed citations
18.
Koskimaki, Jacob E., Esak Lee, William Chen, et al.. (2012). Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors. Angiogenesis. 16(1). 159–170. 17 indexed citations
19.
Koskimaki, Jacob E., Elena Roşca, Corban G. Rivera, et al.. (2012). Serpin-Derived Peptides Are Antiangiogenic and Suppress Breast Tumor Xenograft Growth. Translational Oncology. 5(2). 92–97. 18 indexed citations
20.
Lee, Esak, Elena Roşca, Niranjan B. Pandey, & Aleksander S. Popel. (2011). Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation. The International Journal of Biochemistry & Cell Biology. 43(12). 1812–1821. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026